Synthesis of Sitagliptin Intermediate: A Biocatalytic Breakthrough

Leveraging enzyme power for greener, more efficient pharmaceutical intermediate production.

Get a Quote & Sample

Key Advantages of Our Sitagliptin Intermediate Synthesis

Eco-Friendly Process

Our biocatalytic approach for sitagliptin intermediate synthesis significantly reduces the reliance on harsh chemicals, aligning with green chemistry principles.

Cost-Effectiveness

Utilizing benzylamine as an amino donor in the enzymatic cascade transaminase synthesis for sitagliptin offers a more economical pathway compared to conventional methods.

High Yield and Purity

The optimized multi-enzymatic system and promoter engineering contribute to excellent conversion rates and high purity of the sitagliptin intermediate.

Key Applications

Pharmaceutical Manufacturing

Essential for the large-scale production of Sitagliptin, a vital drug for managing type 2 diabetes, showcasing the critical role in pharmaceutical synthesis.

Drug Discovery & Development

Serves as a high-quality intermediate for researchers and companies engaged in developing new antidiabetic therapies and related compounds.

Biocatalysis Research

Provides a practical case study for advancements in biocatalytic process development, highlighting the efficacy of enzymatic cascades and enzyme engineering.

Sustainable Chemical Production

Represents a forward-thinking approach to green chemistry in pharmaceutical industry, demonstrating how enzymatic routes can replace environmentally taxing chemical processes.